E. Wendy Blosser - Mar 4, 2022 Form 3 Insider Report for Accustem Sciences Inc. (ACUT)

Signature
/s/ Wendy Blosser
Stock symbol
ACUT
Transactions as of
Mar 4, 2022
Transactions value $
$0
Form type
3
Date filed
5/27/2022, 10:37 AM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACUT Common Stock 2K Mar 4, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACUT Options (right to buy) Mar 4, 2022 Common Stock 490K $2.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 49,000 of the options vest on January 25, 2023, 2024 and 2025 and 98,000 vest on January 25, 2026. 122,500 options vest upon the closing of a single equity raise netting not less than $30m for the Company; and 122,500 options vest upon the opening of a commercial CLIA lab in the U.S. no later than the fourth quarter 2023.